Polygenic Score (PGS) ID: PGS005353

Predicted Trait
Reported Trait Type 2 diabetes (T2D)
Mapped Trait(s) type 2 diabetes mellitus (MONDO_0005148)
Released in PGS Catalog: Feb. 26, 2026
Download Score FTP directory
Terms and Licenses
PGS obtained from the Catalog should be cited appropriately, and used in accordance with any licensing restrictions set by the authors. See EBI Terms of Use (https://www.ebi.ac.uk/about/terms-of-use/) for additional details.

Score Details

Score Construction
PGS Name DPRISM_T2DPRS_trainedforAFR_AFRweights
Development Method
Name PRS-CSx
Parameters T2D GWAS summary statistics and LD reference panels (TagIt SNP set, in-house LD estimations) from AFR ancestry. Best phi: 1e-4.
Variants
Original Genome Build hg19
Number of Variants 2,325,981
Effect Weight Type beta
PGS Source
PGS Catalog Publication (PGP) ID PGP000773
Citation (link to publication) Huerta-Chagoya A et al. medRxiv (2025) Preprint
Ancestry Distribution
Source of Variant
Associations (GWAS)
African: 100%
128,695 individuals (100%)
Score Development/Training
African: 100%
6,779 individuals (100%)
PGS Evaluation
African: 100%
4 Sample Sets

Development Samples

Source of Variant Associations (GWAS)
Study Identifiers Sample Numbers Sample Ancestry Cohort(s)
35551307, 32541925
[
  • 43,167 cases
  • , 85,528 controls
]
African American or Afro-Caribbean
(African American, Zulu)
21 cohorts
  • ARIC
  • ,BioMe
  • ,CARDIA
  • ,CFS
  • ,CHS
  • ,FamHS
  • ,GENOA
  • ,GERA
  • ,GeneSTAR
  • ,HANDLS
  • ,HUFS
  • ,HealthABC
  • ,JHS
  • ,MESA
  • ,MVP
  • ,REGARDS
  • ,SAZ
  • ,SIGNET
  • ,WFSM
  • ,WHI
  • ,eMERGE
Score Development/Training
Study Identifiers Sample Numbers Sample Ancestry Cohort(s) Phenotype Definitions & Methods Age of Study Participants Participant Follow-up Time Additional Ancestry Description Additional Sample/Cohort Information
[
  • 1,409 cases
  • , 5,370 controls
]
African American or Afro-Caribbean
(African American)
BioVU

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM023244 PSS012148|
African Ancestry|
12,352 individuals
PGP000773 |
Huerta-Chagoya A et al. medRxiv (2025)
|Pre
Reported Trait: Cardiovascular disease OR: 0.99 [0.93, 1.05]
β: -0.01123
sex, age, genetic principal components Restricted to T2D cases only.
PPM023199 PSS012148|
African Ancestry|
12,352 individuals
PGP000773 |
Huerta-Chagoya A et al. medRxiv (2025)
|Pre
Reported Trait: Type 2 diabetes HR: 1.36 [1.21, 1.53]
OR: 1.68 [1.61, 1.76]
β: 0.52067
AUROC: 0.68035 : 0.12691 sex, age, genetic principal components
PPM023204 PSS012153|
African Ancestry|
2,282 individuals
PGP000773 |
Huerta-Chagoya A et al. medRxiv (2025)
|Pre
Reported Trait: Type 2 diabetes OR: 1.71 [1.52, 1.94]
β: 0.53912
AUROC: 0.64033 : 0.07418 sex, age, genetic principal components
PPM023209 PSS012162|
African Ancestry|
1,155 individuals
PGP000773 |
Huerta-Chagoya A et al. medRxiv (2025)
|Pre
Reported Trait: Type 2 diabetes OR: 1.46 [1.28, 1.66]
β: 0.37919
AUROC: 0.62924 : 0.06363 sex, age, genetic principal components
PPM023219 PSS012148|
African Ancestry|
12,352 individuals
PGP000773 |
Huerta-Chagoya A et al. medRxiv (2025)
|Pre
Reported Trait: Proliferative diabetic retinopathy OR: 1.39 [1.17, 1.65]
β: 0.32872
sex, age, genetic principal components Restricted to T2D cases only.
PPM023224 PSS012148|
African Ancestry|
12,352 individuals
PGP000773 |
Huerta-Chagoya A et al. medRxiv (2025)
|Pre
Reported Trait: Ischemic stroke OR: 1.01 [0.93, 1.11]
β: 0.01484
sex, age, genetic principal components Restricted to T2D cases only.
PPM023229 PSS012148|
African Ancestry|
12,352 individuals
PGP000773 |
Huerta-Chagoya A et al. medRxiv (2025)
|Pre
Reported Trait: End-stage diabetic nephropathy OR: 1.44 [1.2, 1.74]
β: 0.36742
sex, age, genetic principal components Restricted to T2D cases only.
PPM023234 PSS012148|
African Ancestry|
12,352 individuals
PGP000773 |
Huerta-Chagoya A et al. medRxiv (2025)
|Pre
Reported Trait: Diabetic retinopathy OR: 1.28 [1.18, 1.39]
β: 0.24486
sex, age, genetic principal components Restricted to T2D cases only.
PPM023239 PSS012148|
African Ancestry|
12,352 individuals
PGP000773 |
Huerta-Chagoya A et al. medRxiv (2025)
|Pre
Reported Trait: Diabetic nephropathy OR: 1.26 [1.13, 1.4]
β: 0.22875
sex, age, genetic principal components Restricted to T2D cases only.
PPM023214 PSS012168|
African Ancestry|
2,906 individuals
PGP000773 |
Huerta-Chagoya A et al. medRxiv (2025)
|Pre
Reported Trait: Type 2 diabetes OR: 2.62 [2.3, 2.97]
β: 0.96137
AUROC: 0.74575 : 0.23196 sex, age, genetic principal components

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS012168
[
  • 1,060 cases
  • , 1,846 controls
]
African unspecified
(African)
UKB
PSS012153
[
  • 773 cases
  • , 1,509 controls
]
African American or Afro-Caribbean
(African American)
BioMe
PSS012162
[
  • 376 cases
  • , 779 controls
]
African American or Afro-Caribbean MGBB
PSS012148
[
  • 5,366 cases
  • , 6,986 controls
]
African American or Afro-Caribbean
(African American)
AllofUs